Ubs Group Ag Standard Biotools Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

A detailed history of Ubs Group Ag transactions in Standard Biotools Inc. stock. As of the latest transaction made, Ubs Group Ag holds 253,305 shares of LAB stock, worth $425,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
253,305
Previous 175,536 44.3%
Holding current value
$425,552
Previous $310,000 57.42%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.42 - $2.35 $110,431 - $182,757
77,769 Added 44.3%
253,305 $488,000
Q2 2024

Aug 13, 2024
SELL
$1.65 - $2.92 $508,873 - $900,551
-308,408 Reduced 63.73%
175,536 $310,000
Q1 2024

May 13, 2024
BUY
$1.87 - $2.78 $865,290 - $1.29 Million
462,722 Added 2180.39%
483,944 $1.31 Million
Q4 2023

Feb 09, 2024
BUY
$1.59 - $2.73 $8,891 - $15,266
5,592 Added 35.78%
21,222 $46,000
Q3 2023

Nov 09, 2023
SELL
$1.9 - $3.05 $6,004 - $9,638
-3,160 Reduced 16.82%
15,630 $45,000
Q2 2023

Aug 11, 2023
BUY
$1.47 - $2.56 $1,646 - $2,867
1,120 Added 6.34%
18,790 $36,000
Q1 2023

May 12, 2023
SELL
$1.3 - $2.24 $19,241 - $33,154
-14,801 Reduced 45.58%
17,670 $34,000
Q4 2022

Feb 08, 2023
BUY
$0.93 - $1.52 $12,429 - $20,314
13,365 Added 69.95%
32,471 $37,000
Q3 2022

Nov 10, 2022
SELL
$1.1 - $2.06 $11,378 - $21,308
-10,344 Reduced 35.12%
19,106 $21,000
Q2 2022

Aug 10, 2022
SELL
$1.6 - $3.99 $1.05 Million - $2.62 Million
-657,596 Reduced 95.71%
29,450 $47,000
Q1 2022

May 16, 2022
SELL
$2.8 - $3.96 $106,733 - $150,951
-38,119 Reduced 5.26%
687,046 $2.47 Million
Q4 2021

Feb 14, 2022
SELL
$3.63 - $6.13 $228,679 - $386,171
-62,997 Reduced 7.99%
725,165 $2.84 Million
Q3 2021

Nov 15, 2021
SELL
$5.5 - $7.41 $38,329 - $51,640
-6,969 Reduced 0.88%
788,162 $5.19 Million
Q2 2021

Aug 13, 2021
SELL
$4.35 - $6.35 $1.01 Million - $1.48 Million
-233,067 Reduced 22.67%
795,131 $4.9 Million
Q1 2021

May 12, 2021
BUY
$3.94 - $7.09 $1.78 Million - $3.2 Million
451,502 Added 78.29%
1,028,198 $4.65 Million
Q4 2020

Feb 11, 2021
BUY
$5.45 - $8.65 $53,546 - $84,986
9,825 Added 1.73%
576,696 $3.46 Million
Q3 2020

Nov 12, 2020
SELL
$4.34 - $11.43 $1.68 Million - $4.42 Million
-386,543 Reduced 40.54%
566,871 $4.21 Million
Q2 2020

Jul 31, 2020
BUY
$1.85 - $5.29 $1.48 Million - $4.23 Million
800,372 Added 522.98%
953,414 $3.82 Million
Q1 2020

May 01, 2020
BUY
$1.24 - $4.35 $56,989 - $199,921
45,959 Added 42.92%
153,042 $389,000
Q4 2019

Feb 14, 2020
BUY
$2.3 - $5.12 $244,786 - $544,916
106,429 Added 16273.55%
107,083 $373,000
Q3 2019

Nov 14, 2019
SELL
$4.63 - $12.15 $10,412 - $27,325
-2,249 Reduced 77.47%
654 $3,000
Q2 2019

Aug 14, 2019
BUY
$11.49 - $14.17 $6,514 - $8,034
567 Added 24.27%
2,903 $36,000
Q1 2019

May 14, 2019
SELL
$8.47 - $14.36 $60,475 - $102,530
-7,140 Reduced 75.35%
2,336 $31,000
Q4 2018

Feb 14, 2019
BUY
$7.18 - $8.83 $25,007 - $30,754
3,483 Added 58.12%
9,476 $82,000
Q3 2018

Nov 14, 2018
BUY
$5.92 - $8.35 $15,078 - $21,267
2,547 Added 73.91%
5,993 $45,000
Q2 2018

Aug 14, 2018
BUY
$4.86 - $6.24 $16,465 - $21,141
3,388 Added 5841.38%
3,446 $21,000
Q1 2018

May 15, 2018
SELL
$5.75 - $7.97 $13,460 - $18,657
-2,341 Reduced 97.58%
58 $0
Q4 2017

Feb 14, 2018
SELL
$4.46 - $6.45 $6,797 - $9,829
-1,524 Reduced 38.85%
2,399 $14,000
Q3 2017

Nov 14, 2017
BUY
$3.55 - $5.49 $12,123 - $18,748
3,415 Added 672.24%
3,923 $19,000
Q2 2017

Aug 14, 2017
SELL
N/A
-770 Reduced 60.25%
508 $2,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,278
1,278 $7,000

Others Institutions Holding LAB

# of Institutions
143
Shares Held
279M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $132M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email